Tanezumab In Osteoarthritis Of The Hip Or Knee

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis

In brief

The purpose of the study is to test the efficacy and safety of 2 doses of tanezumab compared to oxycodone CR and placebo in patients with osteoarthritis

Key facts

Study ID
NCT00985621
Run by
Pfizer
People needed
614
Starts
2009-10-30
Expected to finish
2011-02-04
Last updated by the study team
2021-05-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.